- Research works
- 103 ▲ 519% vs 2013–17
- Citations
- 2.7k 25.9 per fractional work
- Top-10% rate
- 31.5% record average 16.5%
- Open access
- 73% world 28%
Not ranked overall: China-US (Henan) Hormel Cancer Institute is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
What does China-US (Henan) Hormel Cancer Institute specialise in?
Where its research is concentrated relative to its size: Biochemistry, Genetics and Molecular Biology takes 9.2× the share of its output that it takes of world research.
- Biochemistry, Genetics and Molecular BiologyField · 20.4 works9.2×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 9.2×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 9.2×
- Pharmacology, Toxicology and Pharmaceutics 8.9×
- Immunology and Microbiology 5.8×
- Medicine 1.9×
- Chemistry 1.3×
- Nursing 1.0×
- Agricultural and Biological Sciences 0.4×
- Neuroscience 0.4×
- Earth and Planetary Sciences 0.1×
- Environmental Science 0.0×
- Computer Science 0.0×
- Engineering 0.0×
Which keywords describe research at China-US (Henan) Hormel Cancer Institute?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Cancer Therapy, Inflammation, Tumor Microenvironment, Apoptosis, Targeted Therapy, Metabolism and Cancer Progression.
- Signaling
- Phosphorylation
- Cancer Immunotherapy
- Tumorigenesis
- Innate Immunity
- Gene Expression
- Mutation
- Immune Response
- Epigenetic Regulation
- Cell Proliferation
- Anti-inflammatory
- Pharmacology
- EGFR Mutations
- Transcriptional Regulation
- Clinical Trials
- Metabolism
- Targeted Therapy
- Tumor Microenvironment
- Inflammation
- Cancer
- Cancer Therapy
- Apoptosis
- Cancer Progression
- Antioxidant
- Oxidative Stress
- ALK Inhibitors
- Immunity
- Regulation
- Angiogenesis
- Cell Death
- Gene Expression Regulation
- Metastasis
- DNA Methylation
- Histone Modification
- RNA methylation
- m6A-seq
- HIF-1
- Warburg Effect
- Tumor Suppression
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 39 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 39 words, with their numbers
- Cancer8▲ 15×33 topics
- Inflammation5▲ 5.6×22 topics
- Cancer Therapy5▲ 20×11 topics
- Tumor Microenvironment4▲ 21×7 topics
- Apoptosis3▲ 26×15 topics
- Targeted Therapy3▲ 30×3 topics
- Cancer Progression2▲ 31×3 topics
- Metabolism2▲ 11×10 topics
- Antioxidant2▲ 7.8×16 topics
- Clinical Trials2▲ 7.7×3 topics
- Oxidative Stress2▲ 3.1×11 topics
- Transcriptional Regulation2▲ 29×6 topics
- ALK Inhibitors2▲ 74×1 topic
- EGFR Mutations2▲ 74×1 topic
- Immunity2▲ 11×4 topics
- Pharmacology2▲ 18×13 topics
- Regulation2▲ 8.4×7 topics
- Anti-inflammatory2▲ 15×14 topics
- Angiogenesis2▲ 12×8 topics
- Cell Proliferation2▲ 41×4 topics
- Cell Death1▲ 14×5 topics
- Epigenetic Regulation1▲ 16×3 topics
- Gene Expression Regulation1▲ 31×3 topics
- Immune Response1▲ 6.1×5 topics
- Metastasis1▲ 9.8×4 topics
- Mutation1▲ 18×3 topics
- DNA Methylation1▲ 27×1 topic
- Gene Expression1▲ 5.3×6 topics
- Histone Modification1▲ 44×1 topic
- Innate Immunity1▲ 9.8×4 topics
- RNA methylation1▲ 32×1 topic
- Tumorigenesis1▲ 73×2 topics
- m6A-seq1▲ 32×1 topic
- Cancer Immunotherapy1▲ 18×2 topics
- HIF-11▲ 44×1 topic
- Phosphorylation1▲ 103×2 topics
- Warburg Effect1▲ 44×1 topic
- Signaling1▲ 43×3 topics
- Tumor Suppression1▲ 35×2 topics
Which research topics does China-US (Henan) Hormel Cancer Institute publish most on?
By volume in 2022–2025: Lung Cancer Treatments and Mutations, Epigenetics and DNA Methylation, RNA modifications and cancer and Cancer, Hypoxia, and Metabolism.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 2 Epigenetics and DNA Methylation Molecular Biology 1 works
- 3 RNA modifications and cancer Molecular Biology 1 works
- 4 Cancer, Hypoxia, and Metabolism Cancer Research 1 works
- 5 Cancer Mechanisms and Therapy Pathology and Forensic Medicine 1 works
- 6 Cancer-related Molecular Pathways Oncology 1 works
- 7 Ubiquitin and proteasome pathways Molecular Biology 1 works
- 8 RNA Interference and Gene Delivery Molecular Biology 1 works
- 9 Immunotherapy and Immune Responses Immunology 1 works
- 10 Cancer Immunotherapy and Biomarkers Oncology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has China-US (Henan) Hormel Cancer Institute's research output changed?
Output in 2018–2022 was 519% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Zhengzhou
- Zhengzhou University
- First Affiliated Hospital of Zhengzhou University
- Henan University of Technology
- Henan Agricultural University
- Zhengzhou University of Light Industry
- PLA Information Engineering University
- North China University of Water Resources and Electric Power
- Zhongyuan University of Technology
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.